Rigel Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Amgen USD 26.93B 2.1B 2025-03
Arrowhead Research USD 1.14B 564.68M 2025-03
AstraZeneca USD 26.14B 312M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Celldex Therapeutics USD 693.76M 53.4M 2025-03
Daiichi Sankyo JPY 1.91T 66.22B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ligand Pharmaceuticals USD 309.32M 22.24M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Veracyte USD 383.15M 10.88M 2025-03



Rigel Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.